Stock Rich List
#3875 on the rich list of 14,644 insiders

Steven M. Paul

Director at Seaport Therapeutics; Director at Rapport Therapeutics; Director at Alnylam Pharmaceuticals. Based in Boston, Massachusetts.

$29.1M
in disclosed stock, +$113K (+0.39%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
3875th of 14,644
Companies held
3
Largest holding
SPTX, 54.4% of total
Latest SEC filing
Oct 22, 2026

What the $29.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Seaport Therapeutics SPTX
Common Stock
Directly863,031$18.32$15.8M54.4%Form 4, May 4, 2026
Rapport Therapeutics RAPP
Common Stock
Directly477,642$23.59$11.3M38.8%Form 4, Oct 22, 2026
Rapport Therapeutics RAPP
Common Stock
Through Paul Capital Strategy III Fund LLC77,380$23.59$1.8M6.3%Form 4, Oct 22, 2026
Alnylam Pharmaceuticals ALNY
Common Stock
Directly1,000$147.82$148K0.5%Form 4, Apr 1, 2022

Share counts are the amounts Steven M. Paul reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Open-market trades, last 12 months

DateTradeCompanySharesPriceValueFiling
Oct 22, 2026BoughtRAPP35,714$27.28$974KView

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
3872Normand A. Boulanger
Director, SS&C Technologies Holdings. Windsor, CT
$29.1M−$576K (−1.94%)
3873Tyler Sloat
Chief Financial & Oper Officer, Freshworks. San Mateo, CA
$29.1M−$1.2M (−3.98%)
3874Alexandra W. Schiff
Director, Palantir Technologies. Aventura, FL
$29.1M−$565K (−1.91%)
3875Steven M. Paul
Director, Seaport Therapeutics. Boston, MA
$29.1M+$113K (+0.39%)
3876Jeffrey Jonathan Brown
Chief Executive Officer, Ally Financial. Memphis, TN
$29.0M−$564K (−1.90%)
3877Dennis B. Story
EVP, CFO & Treasurer, Manhattan Associates. Atlanta, GA
$29.0M−$615K (−2.07%)
3878Laszlo Kopits
General Counsel, Datadog. New York, NY
$29.0M−$113K (−0.39%)

Other Seaport Therapeutics insiders

All SPTX insiders

Questions

How much stock does Steven M. Paul own?

Steven M. Paul holds $29,051,517 in listed stock based on SEC filings and current prices, mostly Seaport Therapeutics (SPTX). That ranks 3875th on the Stock Rich List.

Is this Steven M. Paul's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

When did Steven M. Paul last buy or sell stock?

The most recent open-market trade on file is a purchase of 35,714 RAPP shares on Oct 22, 2026 at $27.28.